Veno-occlusive disease-like hepatotoxicity in two children receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney

Pediatr Hematol Oncol. 1998 Jan-Feb;15(1):85-9. doi: 10.3109/08880019809009513.

Abstract

We report two pediatric cases who developed veno-occlusive disease-like hepatotoxicity while receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney. The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the hepatotoxicity developed. Other possible causes of hepatotoxicity were excluded. Recovery was observed with supportive therapy after 2 and 1 weeks, respectively. After recovery, the children tolerated continued chemotherapy without any decrease in the doses of drugs. We conclude that vincristine and actinomycin D were the cause of this rare from of hepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Dactinomycin / administration & dosage
  • Diagnosis, Differential
  • Epirubicin / administration & dosage
  • Hepatic Veno-Occlusive Disease / chemically induced*
  • Humans
  • Infant
  • Kidney Neoplasms / drug therapy*
  • Liver / drug effects
  • Liver / pathology*
  • Male
  • Sarcoma, Clear Cell / drug therapy*
  • Vincristine / administration & dosage
  • Wilms Tumor / drug therapy*

Substances

  • Dactinomycin
  • Epirubicin
  • Vincristine